Form 4: Amneal Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Gautam Patel, a Director of Amneal Pharmaceuticals, Inc., received 283,632 shares of common stock on August 10, 2026.
Summary
- Grant/award: acquired 283,632 Class A Common Stock on August 10, 2026; holds 283,632 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gautam Patel — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Grant/award | Class A Common Stock | 283,632 | — | — | 283,632 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Grant/award (283,632 shares) |
Keywords
insider transaction, Form 4, AMRX, Amneal Pharmaceuticals, Inc., neutral, Gautam Patel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.